Cherry Yin‐Yi Chang
- Reproductive Medicine top 5%
- Endometriosis Research and Treatment 14
- Ovarian cancer diagnosis and treatment 3
- Obstetrics and Gynecology top 5%
- Gynecological conditions and treatments 3
- Endometrial and Cervical Cancer Treatments 3
- Uterine Myomas and Treatments 3
-
- Reproductive System and Pregnancy 7
-
- Cancer Genomics and Diagnostics 3
- MicroRNA in disease regulation 2
In The Last Decade
Cherry Yin‐Yi Chang
33 papers receiving 283 citations
Peers
Comparison fields: 5 of 75
- Reproductive Medicine 124
- Obstetrics and Gynecology 91
- Immunology 86
- Cancer Research 32
- Hematology 13
Countries citing papers authored by Cherry Yin‐Yi Chang
This map shows the geographic impact of Cherry Yin‐Yi Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cherry Yin‐Yi Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cherry Yin‐Yi Chang more than expected).
Fields of papers citing papers by Cherry Yin‐Yi Chang
This network shows the impact of papers produced by Cherry Yin‐Yi Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cherry Yin‐Yi Chang. The network helps show where Cherry Yin‐Yi Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cherry Yin‐Yi Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 0 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 1 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 3 | |
| 17 | 2018 | 41 | |
| 18 | 2011 | 4 | |
| 19 | 2011 | 34 | |
| 20 | 2003 | 20 |
About Cherry Yin‐Yi Chang
Cherry Yin‐Yi Chang is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Immunology, having authored 36 papers that have together received 287 indexed citations. Recurring topics across this work include Endometriosis Research and Treatment (14 papers), Reproductive System and Pregnancy (7 papers), Gynecological conditions and treatments (3 papers), Cancer Genomics and Diagnostics (3 papers), Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (3 papers), Uterine Myomas and Treatments (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Reproductive Medicine (124 citations), Obstetrics and Gynecology (91 citations) and Immunology (86 citations). Cherry Yin‐Yi Chang has collaborated with scholars based in Taiwan, Australia and China. Frequent co-authors include Jim Jinn‐Chyuan Sheu, Wu-Chou Lin, Fuu‐Jen Tsai, Chih‐Mei Chen, Lei Wan, Ming‐Tsung Lai, Li Sun, Wei‐Yong Lin, An‐Jen Chiang and Lun-Chien Lo. Their work appears in journals such as PLoS ONE, Biochemistry and American Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.